Fecal transplant for schizophrenia symptoms
Treatments studied
Part of Mental health clinical trials.
This study tests whether a fecal microbiota transplant (FMT) — a procedure that transfers healthy bacteria from a donor's stool into your gut — can improve schizophrenia symptoms. It may help because gut bacteria can affect the brain, but more research is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with schizophrenia for 5 years or less.
- You are currently taking one of the recommended antipsychotic medications for schizophrenia.
- You have moderate or more severe symptoms, with a score of at least 60 on a standard schizophrenia symptoms test (PANSS).
- You have at least a junior high school education.
- You are not pregnant or breastfeeding, and you do not have serious medical conditions like heart failure, kidney or liver failure, cancer, or certain gut diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a fecal microbiota transplant (FMT), which introduces healthy gut bacteria from a donor, can improve eating disorder symptoms and digestive issues in people with anorexia nervosa. It may help by balancing the gut microbiome, which could affect mood and appetite.
This study tests if transplanting healthy bacteria into the gut can help children and young adults with autism who also have stomach problems. It aims to improve both digestive and behavioral symptoms.
This study tests whether a stool transplant from a healthy donor can help treat depression. It aims to see if improving gut bacteria can improve mood and depression symptoms.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This trial tests whether transferring stool bacteria to the gut (fecal microbiota transplantation) can reduce symptoms of irritable bowel syndrome with constipation. It may help by changing the gut microbiome, but you must meet safety and health requirements.
This trial tests whether a fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor into your gut, can reduce severe irritable bowel syndrome (IBS) symptoms. FMT is being studied as a possible new treatment for people with IBS that hasn't improved with other treatments.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.